The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 412 participants.
Also called NCT01320345
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 412 participants
- Registry
-
NCT01320345 -
ACTRN12611000249954
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Hong Kong SAR China, New Zealand, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT01320345. Randomized; quadruple masking; primary purpose treatment. Start 2016-11-03 (actual); primary completion 2026-08-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
- Acronym
- FAME 1 EYE
- Condition
- Type 1 Diabetes Mellitus
- Condition
- Diabetic Retinopathy
- Condition
- Diabetic Nephropathies
- Intervention (Drug)
- Fenofibrate
- Intervention (Drug)
- Inert lactose placebo
- Lead sponsor
- University of Sydney
- Collaborator
- National Health and Medical Research Council, Australia
- Collaborator
- Juvenile Diabetes Research Foundation Australia
- Collaborator
- Mylan Pharmaceuticals Inc
Record details
- Record id
cardio:ct-nct01320345- Content hash
82f9285c2234a19857e074ba8faa7200e13be4a844275c7e4910f76a0001bfaf